# FDA 483 - Aurobindo Pharma Limited - May 10, 2022

Source: https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/32976071-2001-4f14-887c-76d96e0a30e8

> FDA 483 for Aurobindo Pharma Limited on May 10, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aurobindo Pharma Limited
- Inspection Date: 2022-05-10
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2026-01-28](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/4402f9cb-7684-4577-a119-d85aa7d6b1c3)

## Related Officers

- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/darren-s-brown/389a4d1f-7f34-42cd-bdc8-5bebd41aff56)
- [Research Specialist II](https://www.globalkeysolutions.net/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)

Company: https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c